Cargando…
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Overview: We assessed the role of age and disease activity as new factors contributing to establish the risk of progressive multifocal leucoencephalopathy in multiple sclerosis patients treated with natalizumab in 36 University Hospitals in Europe. We performed the study in 1,307 multiple sclerosis...
Ejemplares similares
-
microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate
por: Dominguez-Mozo, María I., et al.
Publicado: (2022) -
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis
por: Picón, Carmen, et al.
Publicado: (2021) -
Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection
por: Alvarez Bravo, G., et al.
Publicado: (2020) -
Encefalitis anti-NMDA-R secundaria a infección por SARS-CoV-2
por: Álvarez Bravo, G., et al.
Publicado: (2020) -
Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)